Abrams' Clinical Drug Therapy: Rationales
L
T
F L
T
F L
T
F L
T
F
for Nursing Practice FT L FT L FT L
13th Edition
L
T
F
by Geralyn Frandsen & Sandra Pennington
L
FT L
FT FT L FT L FT L
Complete Chapter Guide 1-61 With Rationales| A+ PASS
L
FT L
FT L
FT L
FT L
FT L
FT L
FT
1|P a g e
L
FT L
FT FT L FT L FT L
, Table of Content FT L FT L
FT SECTION 1 The Conceptual Framework of Pharmacology
L FT L FT L FT L FT L FT L FT L
FT Chapter 1 The Foundation of Pharmacology: Quality and Safety
L FT L L
FT FT L L
FT FT L L
FT L
FT L
FT
L
FT Chapter 2 Basic Concepts and Processes FT L FT L FT L FT L FT L
Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
L
FT FT L L
FT L
FT L
FT L
FT L
FT FT L L
FT L
FT
SECTION 2 Drug Therapy Throughout the Lifespan FT L FT L FT L FT L L
FT FT L
Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in
FT L FT L L
FT FT L L
FT L
FT L
FT FTL L
FT L
FT FT L L
FT L
FT
Pediatrics
L
FT
Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients
FT L FT L L
FT FT L FT L FT L FT L FT L FT L FT L
L
FT Chapter 6 Pharmacology and the Care of Pregnant or Lactating Woman
FT L L
FT FT L L
FT L
FT L
FT L
FT L
FT L
FT L
FT
L
FT Chapter 7 Pharmacology and Women‘s HealthFT L FT L FT L L
FT FT L
Chapter 8 Pharmacology and Men‘s Health
FT L FT L L
FT FT L FT L
SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems L
FT L
FT FT L FT L L
FT FT L FT L FT L
Chapter 9 Drug Therapy for Coagulation Disorders
L
FT FT L T
F L L
FT L
FT L
FT
L
FT Chapter 10 Drug Therapy for Dyslipidemia FT L L
FT L
FT FT L L
FT
Chapter 11 Drug Therapy for Hematopoietic Disorders
L
FT L
FT L
FT L
FT L
FT L
FT
L
FT Chapter 12 Drug Therapy: Immunizations FT L L
FT L
FT FT L
Chapter 13 Drug Therapy to Decrease Immunity
FT L FT L FT L FT L FT L FT L
L
FT Chapter 14 Drug Therapy for the Treatment of Cancer
FT L FT L FT L FT L FT L L
FT FT L FT L
SECTION 4 Drugs Affecting Inflammation and Infection L
FT L
FT FT L FT L FT L L
FT
Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents
L
FT FT L L
FT L
FT L
FT L
FT FT L FT L FT L
L
FT Chapter 16 Drug Therapy to Decrease Pain, Fever, and Inflammation
FT L L
FT L
FT FT L FT L FT L FT L FT L L
FT
L
FT Chapter 17 Drug Therapy With Corticosteroids
FT L L
FT L
FT FT L FT L
Chapter 18 Drug Therapy With Beta-Lactam Antibacterial Agents
FT L FT L FT L FT L FT L FT L FT L
L
FT Chapter 19 Drug Therapy With Aminoglycosides and Fluoroquinolones
L
FT L
FT L
FT T
FL L
FT L
FT FT L
Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics
FT L FT L FT L FT L FT L FT L FT L L
FT L
FT
L
FT Chapter 21 Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents
FT L L
FT L
FT FT L FT L L
FT FT L L
FT FT L
L
FT Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease
FT L FT L L
FT FTL L
FT L
FT FT L L
FT L
FT L
FT
L
FT Chapter 23 Drug Therapy for Viral Infections
FT L L
FT L
FT FT L L
FT FT L
2|P a g e L
FT L
FT FT L FT L FT L
,Chapter 24 Drug Therapy for Fungal Infections
FT L FT L FT L FT L FT L FT L
FT Chapter 25 Drug Therapy for Parasitic Infections
L FTL L
FT L
T
F FT L FT L L
FT
SECTION 5 Drugs Affecting the Cardiovascular System FT L L
FT L
FT FT L FT L FT L
Chapter 26 Drug Therapy for Hypertension
FT L FT L FT L FT L FT L
FT Chapter 27 Drug Therapy for Dysrhythmias
L FTL L
FT L
FT L
FT L
FT
Chapter 28 Drug Therapy for Coronary Heart Disease
FT L L
FT L
T
F FT L L
FT L
FT L
FT
FT Chapter
L L
FT 29 L
FT Drug L
FT Therapy FT Lfor FT Shock
L L
FT and
FT Hypotension Chapter 30 Drug Therapy for Heart
L FT L L
FT L
FT FT L FT L L
FT
FT Failure
L
SECTION 6 Drugs Affecting the Respiratory System FT L L
FT L
FT FT L FT L FT L
Chapter 31 Drug Therapy for Nasal Congestion and Cough
FT L FT L FT L FT L FT L FT L L
FT L
FT
Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response
L
FT FT L L
FT L
FT FT L FT L L
FT L
FT L
FT L
FT
FT Chapter 33 Drug Therapy for Asthma and Bronchoconstriction
L FT L L
FT L
FT L
FT L
FT L
FT L
FT
SECTION 7 Drugs Affecting the Renal and Digestive Systems FT L L
FT FT L FT L FT L FT L FT L FT L
Chapter 34 Drug Therapy for Fluid Volume Excess
FT L FT L FT L FT L FT L L
FT FT L
Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements
L
FT FT L L
FT FT L L
FT L
FT L
FT L
FT
FT Chapter 36 Drug Therapy for Weight Management
L FT L L
FT L
FT L
FT L
FT FT L
Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity
L
FT FT L L
FT L
FT L
FT FT L FT L L
FT L
FT
FT Chapter 38 Drug Therapy for Nausea and Vomiting
L FT L L
FT L
FT L
FT L
FT FT L FTL
Chapter 39 Drug Therapy for Constipation and Elimination Problems
L
FT FT L L
FT L
FT L
FT L
FT L
FT L
FT
FT Chapter 40 Drug Therapy for Diarrhea
L FT L L
FT L
FT L
FT L
FT
SECTION 8 Drugs Affecting the Endocrine System L
FT L
FT L
FT L
FT L
FT L
FT
FT Chapter 41 Drug Therapy for Diabetes Mellitus
L FT L L
FT L
FT L
FT L
FT FT L
Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism
FT L FT L FT L FT L FT L FT L FT L
FT Chapter 43 Drug Therapy for Pituitary and Hypothalamic Dysfunction
L FT L L
FT L
FT L
FT L
FT FT L FT L L
FT
FT Chapter 44 Drug Therapy to Regulate Calcium and Bone Metabolism
L FT L L
FT L
FT L
FT FT L FT L FT L L
FT FT L
FT Chapter 45 Drug Therapy for Addison‘s Disease and Cushing‘s Disease
L FT L L
FT L
FT L
FT L
FT FTL FT L FT L L
FT
FT Section 9 Drugs Affecting the Autonomic and Central Nervous
L FT L L
FT FT L L
FT L
FT L
FT L
FT FT L
L
FT System
3|P a g e L
FT L
FT FT L FT L FT L
, Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of
L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT L
FT
Drug Therapy
L
FT L
FT
4|P a g e
L
FT L
FT FT L FT L FT L